INS and Insulin resistance: Recent studies have demonstrated that sphingolipids, in particular ceramides, could contribute to insulin resistance by inhibiting the activation of protein kinase B (PKB), which leads to the blocking of the translocation of glucose transporter 4 (GLUT4) and the consequent suppression of insulin-stimulated glucose uptake and glycogen synthesis.